SEPTIN4 and breast carcinoma: We profiled endogenous ARTS across a panel of breast cancer cell lines by immunoblot (Fig. S1E) and tested its functional role using ARTS-knockdown MDA-MB-231 cells (Fig. S1F) and ARTS-overexpressing MCF-7 cells (Fig. S1G) treated with DOX or docetaxel (DTX).